Abstract
Evaluation of: Hayashi K, Saruta T, Goto Y, Ishii M; JATOS Study Group: Impact of renal function on cardiovascular events in elderly hypertensive patients treated with efonidipine. Hypertens. Res. 33(11), 1211–1220 (2010). Antihypertensive therapy with efonidipine-based regimens increased estimated glomerular filtration rate (eGFR) throughout the trial period in elderly patients with hypertension in both strict- and mild-treatment groups. The incidence of cardiovascular events was higher in patients with proteinuria than in those without proteinuria at baseline, while disappearance of proteinuria during antihypertensive therapy was closely associated with a reduced incidence of cardiovascular events. Furthermore, cardiovascular event rate was increased in patients with greater declines in eGFR during the study period of 2 years, although baseline eGFR did not correlate with the incidence of cardiovascular events. These findings have implications for therapeutic strategies in treating hypertension with regard to renal protection and cardiovascular events in elderly hypertensive patients.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
